Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. Australia
  4. Australian Stock Exchange
  5. Sonic Healthcare Limited
  6. News
  7. Summary
    SHL   AU000000SHL7

SONIC HEALTHCARE LIMITED

(SHL)
  Report
Delayed Australian Stock Exchange  -  12:10 2022-12-02 am EST
32.19 AUD   +1.23%
11/29Iron Ore Rebound Lifts Australian Shares, Offsets Losses Stemming From China Unrest
MT
11/28Microba Life Sciences Surges 64% After Securing $12 Million Investment from Sonic Healthcare
MT
11/28Microba Life Sciences Limited, Sonic Healthcare Limited - Special Call
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Sonic Healthcare Annual Profit, Dividend Increases

08/23/2022 | 05:29pm EST

By David Winning


SYDNEY--Sonic Healthcare Ltd. said its annual profit rose by 11%, reflecting strong volumes of Covid-19 tests and a recovery in demand for other services as many countries shifted toward treating the virus as endemic.

Sonic said its net profit totaled 1.46 billion Australian dollars (US$1.00 billion) in the 12 months through June, up from A$1.32 billion a year earlier. Directors of the company declared a final dividend of 60 Australian cents a share, up from a payout of 55 cents a year earlier.

Sonic's laboratories have been a key part of many countries' response to the pandemic, analyzing samples daily from tens of thousands of people suspected of having Covid-19. On Wednesday, Sonic said annual Covid-19 revenue rose by 13% compared to a year ago when currency swings were stripped out.

However, demand for PCR tests has begun to fall as countries let the virus circulate in the community and rely more on at-home testing kits. That is threatening to weaken a key pillar of Sonic's profits. At the same time, Sonic is facing an acceleration in cost inflation in many geographies, including in Australia and Europe, which could eat into profit margins.

Still, the revenue windfall from conducting Covid-19 tests on behalf of governments has strengthened Sonic's balance sheet. Analysts say profit margins on Covid-19 tests are higher than the company's traditional pathology business. Sonic's gearing--a measure of debt relative to equity--was at a record-low level at the end of June.

Sonic's strong cash flow generation has stoked speculation about how the company will use surplus capital. In February, Sonic said it would buy back shares worth up to A$500 million after completing around A$585 million of acquisitions. Some analysts expect Sonic to remain on the hunt for deals world-wide as it seeks to keep earnings momentum going.

On Wednesday, Sonic said its buyback was well-progressed and it had A$1.6 billion of available liquidity.

Sonic said its full-year revenue rose by 6.7% to A$9.34 billion, while its earnings before interest, tax, depreciation and amortization--or Ebitda--improved by 11% to A$2.8 billion. Stripping out the boost from Covid-19 tests, Sonic said revenue from its base business rose by 2.1% after the impact of currency swings was excluded.


Write to David Winning at david.winning@wsj.com


(END) Dow Jones Newswires

08-23-22 1929ET

All news about SONIC HEALTHCARE LIMITED
11/29Iron Ore Rebound Lifts Australian Shares, Offsets Losses Stemming From China Unrest
MT
11/28Microba Life Sciences Surges 64% After Securing $12 Million Investment from Sonic Healt..
MT
11/28Microba Life Sciences Limited, Sonic Healthcare Limited - Special Call
CI
11/28Microba Life Sciences Limited and Sonic Healthcare Limited Enter into Agreement to Excl..
CI
11/17Sonic Healthcare's July-October EBTIDA Falls 37%
MT
11/16Sonic Healthcare Seeks Business Acquisitions
CI
11/16Transcript : Sonic Healthcare Limited - Shareholder/Analyst Call
CI
09/25Sonic Healthcare Limited Announces Board Changes
CI
09/06SONIC HEALTHCARE LIMITED : Ex-dividend day for final dividend
FA
08/31Testing, Treatment, and Vaccines are the Three Ways Companies Can Fight Monkeypox (SKHH..
AQ
More news
Financials
Sales 2023 8 145 M 5 524 M 5 524 M
Net income 2023 770 M 522 M 522 M
Net Debt 2023 1 028 M 697 M 697 M
P/E ratio 2023 20,0x
Yield 2023 3,14%
Capitalization 15 334 M 10 400 M 10 400 M
EV / Sales 2023 2,01x
EV / Sales 2024 1,96x
Nbr of Employees 41 000
Free-Float 97,2%
Chart SONIC HEALTHCARE LIMITED
Duration : Period :
Sonic Healthcare Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SONIC HEALTHCARE LIMITED
Short TermMid-TermLong Term
TrendsBearishNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 15
Last Close Price 32,19 AUD
Average target price 34,30 AUD
Spread / Average Target 6,57%
EPS Revisions
Managers and Directors
Colin Stephen Goldschmidt Chief Executive Officer, MD & Executive Director
Christopher David Wilks CFO, Finance Director & Executive Director
Mark R. Compton Chairman
Louis James Panaccio Independent Non-Executive Director
Kathryn Dianne Spargo Independent Non-Executive Director
Sector and Competitors